Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2‐Year Durable Response

For pediatric patients with high‐grade gliomas, standard‐of‐care treatment includes surgery, chemotherapy, and radiation therapy; however, most patients ultimately succumb to their disease. With advances in genomic characterization of pediatric high‐grade gliomas, the use of targeted therapies in co...

Descripción completa

Detalles Bibliográficos
Autores principales: Valiakhmetova, Andge, Gorelyshev, Sergey, Konovalov, Alexander, Trunin, Yuri, Savateev, Alexander, Kram, David E., Severson, Eric, Hemmerich, Amanda, Edgerly, Claire, Duncan, Daniel, Britt, Nicholas, Huang, Richard S.P., Elvin, Julia, Miller, Vincent, Ross, Jeffrey S., Gay, Laurie, McCorkle, Joshua, Rankin, Andrew, Erlich, Rachel L., Chudnovsky, Yakov, Ramkissoon, Shakti H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Precision Medicine Clinic: Molecular Tumor Board
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011619/
https://www.ncbi.nlm.nih.gov/pubmed/32043779
http://dx.doi.org/10.1634/theoncologist.2019-0603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011619/
https://www.ncbi.nlm.nih.gov/pubmed/32043779
http://dx.doi.org/10.1634/theoncologist.2019-0603

Ejemplares similares